Future technology-enabled care for diabetes and hyperglycemia in the hospital setting.

Alex Renato Montero, Jeffrey S Dubin, Paul Sack, Michelle F Magee
Author Information
  1. Alex Renato Montero: MedStar Diabetes Institute, Washington, DC 20010, United States.
  2. Jeffrey S Dubin: MedStar Washington Hospital Center, Washington, DC 20010, United States.
  3. Paul Sack: MedStar Diabetes Institute, Washington, DC 20010, United States.
  4. Michelle F Magee: MedStar Diabetes Institute, Washington, DC 20010, United States.

Abstract

Patients with diabetes are increasingly common in hospital settings where optimal glycemic control remains challenging. Inpatient technology-enabled support systems are being designed, adapted and evaluated to meet this challenge. Insulin pump use, increasingly common in outpatients, has been shown to be safe among select inpatients. Dedicated pump protocols and provider training are needed to optimize pump use in the hospital. Continuous glucose monitoring (CGM) has been shown to be comparable to usual care for blood glucose surveillance in intensive care unit (ICU) settings but data on cost effectiveness is lacking. CGM use in non-ICU settings remains investigational and patient use of home CGM in inpatient settings is not recommended due to safety concerns. Compared to unstructured insulin prescription, a continuum of effective electronic medical record-based support for insulin prescription exists from passive order sets to clinical decision support to fully automated electronic Glycemic Management Systems. Relative efficacy and cost among these systems remains unanswered. An array of novel platforms are being evaluated to engage patients in technology-enabled diabetes education in the hospital. These hold tremendous promise in affording universal access to hospitalized patients with diabetes to effective self-management education and its attendant short/long term clinical benefits.

Keywords

References

  1. Diabetes Care. 2014 Oct;37(10):2702-9 [PMID: 25011947]
  2. BMJ Open Diabetes Res Care. 2018 Mar 02;6(1):e000499 [PMID: 29527311]
  3. Diabetes Care. 2013 Oct;36(10):2960-7 [PMID: 23835695]
  4. J Am Med Inform Assoc. 2014 Jul-Aug;21(4):742-50 [PMID: 24272163]
  5. Endocr Pract. 2009 Jul-Aug;15(5):415-24 [PMID: 19491071]
  6. J Diabetes Sci Technol. 2017 Sep;11(5):1036-1044 [PMID: 28429611]
  7. Diabetes Care. 2010 Oct;33(10):2181-3 [PMID: 20664017]
  8. Endocr Pract. 2011 Nov-Dec;17(6):853-61 [PMID: 21550947]
  9. Diabetes Care. 2018 Aug;41(8):1579-1589 [PMID: 29936424]
  10. Endocr Pract. 2014 Dec;20(12):1265-73 [PMID: 25100371]
  11. J Diabetes Sci Technol. 2012 Sep 01;6(5):995-1002 [PMID: 23063024]
  12. Diabetes Care. 2019 Jan;42(Suppl 1):S173-S181 [PMID: 30559241]
  13. Diabetes Technol Ther. 2016 Feb;18(2):100-3 [PMID: 26783996]
  14. N Engl J Med. 2018 Aug 09;379(6):547-556 [PMID: 29940126]
  15. Diabetes Technol Ther. 2013 Mar;15(3):241-5 [PMID: 23360391]
  16. Curr Diab Rep. 2018 Aug 17;18(10):81 [PMID: 30120619]
  17. Can J Diabetes. 2014 Apr;38(2):126-33 [PMID: 24690507]
  18. J Diabetes Sci Technol. 2017 Sep;11(5):1028-1035 [PMID: 28290224]
  19. Diabetes Technol Ther. 2015 Oct;17(10):685-92 [PMID: 26355756]
  20. J Diabetes Sci Technol. 2015 Aug 31;10(2):325-9 [PMID: 26330394]
  21. Diabetes Educ. 2014 May;40(3):344-350 [PMID: 24557596]
  22. Endocr Pract. 2010 May-Jun;16(3):389-97 [PMID: 20061296]
  23. J Diabetes Sci Technol. 2018 Jan;12(1):47-52 [PMID: 29251064]
  24. Sensors (Basel). 2017 Jan 14;17(1): [PMID: 28098809]
  25. Kidney Int. 2019 Sep;96(3):593-596 [PMID: 31133457]
  26. Endocr Pract. 2006 Jul-Aug;12(4):358-62 [PMID: 16901792]
  27. J Diabetes Sci Technol. 2014 May;8(3):473-8 [PMID: 24876608]
  28. J Eval Clin Pract. 2010 Feb;16(1):202-5 [PMID: 20367835]
  29. Curr Diab Rep. 2017 Jul;17(7):52 [PMID: 28573408]
  30. J Diabetes Complications. 2014 Nov-Dec;28(6):869-73 [PMID: 25087192]
  31. J Diabetes Sci Technol. 2019 May;13(3):522-532 [PMID: 30198324]
  32. Lancet Diabetes Endocrinol. 2019 May;7(5):368-377 [PMID: 30935872]
  33. J Diabetes Sci Technol. 2017 Jan;11(1):12-16 [PMID: 27555601]
  34. Endocr Pract. 2010 Mar-Apr;16(2):209-18 [PMID: 20061280]
  35. J Clin Endocrinol Metab. 2012 Dec;97(12):4383-9 [PMID: 22996145]
  36. Am J Manag Care. 2010;16(12):892-6 [PMID: 21348559]
  37. J Hosp Med. 2013 Dec;8(12):721-7 [PMID: 24227761]
  38. Diabetes Care. 2015 Dec;38(12):e202-3 [PMID: 26519335]
  39. Diabetes Care. 2018 May;41(5):917-928 [PMID: 29567642]
  40. J Diabetes Sci Technol. 2018 Jan;12(1):53-59 [PMID: 29237289]
  41. Diabetes Technol Ther. 2010 May;12(5):347-51 [PMID: 20388044]

Grants

  1. R34 DK109503/NIDDK NIH HHS

Word Cloud

Created with Highcharts 10.0.0diabeteshospitalsettingssupportuseremainstechnology-enabledpumpContinuousglucoseCGMcareinsulineducationincreasinglycommonsystemsevaluatedshownamongmonitoringcostprescriptioneffectiveelectronicclinicaldecisionpatientsPatientsoptimalglycemiccontrolchallengingInpatientdesignedadaptedmeetchallengeInsulinoutpatientssafeselectinpatientsDedicatedprotocolsprovidertrainingneededoptimizecomparableusualbloodsurveillanceintensiveunitICUdataeffectivenesslackingnon-ICUinvestigationalpatienthomeinpatientrecommendedduesafetyconcernsComparedunstructuredcontinuummedicalrecord-basedexistspassiveordersetsfullyautomatedGlycemicManagementSystemsRelativeefficacyunansweredarraynovelplatformsengageholdtremendouspromiseaffordinguniversalaccesshospitalizedself-managementattendantshort/longtermbenefitsFuturehyperglycemiasettingClinicalsubcutaneousinfusionDiabetesInpatientsPatientSelf-management

Similar Articles

Cited By